Mersana Therapeutics: We're About To Find Out If ADC Platform Is More Tolerable

Core Insights - Mersana Therapeutics is an early phase biotech company that has encountered difficulties in recent years, leading to the shelving of several clinical candidates that were once considered promising [1] Company Overview - Mersana Therapeutics operates in the biotechnology sector and has faced significant challenges, particularly in the development of its clinical candidates [1] Industry Context - The biotech industry is characterized by high risks and potential pitfalls, necessitating thorough due diligence by investors to avoid losses [1]